MAPT and Cognitive impairment: Although higher levels of both P-tau species were associated with worse cognitive impairment at baseline, associations with cognitive decline did not reach significance, unlike in a previous report.17 This loss of significance is likely explained by the inclusion of only a subgroup of the initial E-DLB cohort in this study.